Clonally expanded plasma cell lineages in SARS-CoV-2 produce specific neutralizing antibodies

The immune response to infection by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of the ongoing coronavirus

Read more

Zinc supplementation bolsters repurposed antivirals against SARS-CoV-2

Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Read more

Leukemia and Childhood Infection Hypothesis

Leukemia is the most common form of childhood cancers, with a prevalence rate of 10 – 45 per 100,0000 children

Read more